Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Candidate gene analysis for Alzheimer's disease in adults with Down syndrome.

Lee JH, Lee AJ, Dang LH, Pang D, Kisselev S, Krinsky-McHale SJ, Zigman WB, Luchsinger JA, Silverman W, Tycko B, Clark LN, Schupf N.

Neurobiol Aging. 2017 Aug;56:150-158. doi: 10.1016/j.neurobiolaging.2017.04.018. Epub 2017 May 3.

2.

Polymorphisms in BACE2 may affect the age of onset Alzheimer's dementia in Down syndrome.

Mok KY, Jones EL, Hanney M, Harold D, Sims R, Williams J, Ballard C, Hardy J.

Neurobiol Aging. 2014 Jun;35(6):1513.e1-5. doi: 10.1016/j.neurobiolaging.2013.12.022. Epub 2013 Dec 27. Erratum in: Neurobiol Aging. 2014 Nov;35(11):2659. Neurobiol Aging. 2014 Dec;35(12):2886.

3.

Candidate genes for Alzheimer's disease are associated with individual differences in plasma levels of beta amyloid peptides in adults with Down syndrome.

Schupf N, Lee A, Park N, Dang LH, Pang D, Yale A, Oh DK, Krinsky-McHale SJ, Jenkins EC, Luchsinger JA, Zigman WB, Silverman W, Tycko B, Kisselev S, Clark L, Lee JH.

Neurobiol Aging. 2015 Oct;36(10):2907.e1-10. doi: 10.1016/j.neurobiolaging.2015.06.020. Epub 2015 Jun 19.

4.

The impact of risk factors of Alzheimer's disease in the Down syndrome.

Folin M, Baiguera S, Conconi MT, Pati T, Grandi C, Parnigotto PP, Nussdorfer GG.

Int J Mol Med. 2003 Feb;11(2):267-70.

PMID:
12525890
5.

Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients.

Asai M, Kawakubo T, Mori R, Iwata N.

Yakugaku Zasshi. 2017;137(7):801-805. doi: 10.1248/yakushi.16-00236-2. Review. Japanese.

6.

Genetic association of a cystatin C gene polymorphism with late-onset Alzheimer disease.

Finckh U, von der Kammer H, Velden J, Michel T, Andresen B, Deng A, Zhang J, Müller-Thomsen T, Zuchowski K, Menzer G, Mann U, Papassotiropoulos A, Heun R, Zurdel J, Holst F, Benussi L, Stoppe G, Reiss J, Miserez AR, Staehelin HB, Rebeck GW, Hyman BT, Binetti G, Hock C, Growdon JH, Nitsch RM.

Arch Neurol. 2000 Nov;57(11):1579-83.

PMID:
11074789
7.

Association of variants within APOE, SORL1, RUNX1, BACE1 and ALDH18A1 with dementia in Alzheimer's disease in subjects with Down syndrome.

Patel A, Rees SD, Kelly MA, Bain SC, Barnett AH, Thalitaya D, Prasher VP.

Neurosci Lett. 2011 Jan 7;487(2):144-8. doi: 10.1016/j.neulet.2010.10.010. Epub 2010 Oct 12.

PMID:
20946940
8.

Down Syndrome, Partial Trisomy 21, and Absence of Alzheimer's Disease: The Role of APP.

Doran E, Keator D, Head E, Phelan MJ, Kim R, Totoiu M, Barrio JR, Small GW, Potkin SG, Lott IT.

J Alzheimers Dis. 2017;56(2):459-470. doi: 10.3233/JAD-160836.

9.

Flanking markers of cystatin c (CST3) gene do not show association with Alzheimer's disease.

Helisalmi S, Väkevä A, Hiltunen M, Soininen H.

Dement Geriatr Cogn Disord. 2009;27(4):318-21. doi: 10.1159/000209278. Epub 2009 Mar 17.

PMID:
19293566
10.

No association between the cystatin C gene polymorphism and Alzheimer's disease: a case-control study in an Italian population.

Monastero R, Camarda C, Cefalù AB, Caldarella R, Camarda LK, Noto D, Averna MR, Camarda R.

J Alzheimers Dis. 2005 Aug;7(4):291-5.

PMID:
16131730
11.

Association studies testing for risk for late-onset Alzheimer's disease with common variants in the beta-amyloid precursor protein (APP).

Nowotny P, Simcock X, Bertelsen S, Hinrichs AL, Kauwe JS, Mayo K, Smemo S, Morris JC, Goate A.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):469-74.

PMID:
17427190
12.

Variants in CYP17 and CYP19 cytochrome P450 genes are associated with onset of Alzheimer's disease in women with down syndrome.

Chace C, Pang D, Weng C, Temkin A, Lax S, Silverman W, Zigman W, Ferin M, Lee JH, Tycko B, Schupf N.

J Alzheimers Dis. 2012;28(3):601-12. doi: 10.3233/JAD-2011-110860.

13.

Association between genetic variants in sortilin-related receptor 1 (SORL1) and Alzheimer's disease in adults with Down syndrome.

Lee JH, Chulikavit M, Pang D, Zigman WB, Silverman W, Schupf N.

Neurosci Lett. 2007 Sep 25;425(2):105-9. Epub 2007 Aug 25.

14.

Earlier onset of Alzheimer's disease in men with Down syndrome.

Schupf N, Kapell D, Nightingale B, Rodriguez A, Tycko B, Mayeux R.

Neurology. 1998 Apr;50(4):991-5.

PMID:
9566384
15.

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.

Lai F, Kammann E, Rebeck GW, Anderson A, Chen Y, Nixon RA.

Neurology. 1999 Jul 22;53(2):331-6.

PMID:
10430422
16.

Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.

García-Cerro S, Rueda N, Vidal V, Lantigua S, Martínez-Cué C.

Neurobiol Dis. 2017 Oct;106:76-88. doi: 10.1016/j.nbd.2017.06.010. Epub 2017 Jun 21.

PMID:
28647555
17.

Cystatin C and apoe polymorphisms in Italian Alzheimer's disease.

Nacmias B, Bagnoli S, Tedde A, Cellini E, Guarnieri BM, Bartoli A, Serio A, Piacentini S, Sorbi S.

Neurosci Lett. 2006 Jan 9;392(1-2):110-3. Epub 2005 Sep 26.

PMID:
16188386
18.

APOE and AβPP gene variation in cortical and cerebrovascular amyloid-β pathology and Alzheimer's disease: a population-based analysis.

Peuralinna T, Tanskanen M, Mäkelä M, Polvikoski T, Paetau A, Kalimo H, Sulkava R, Hardy J, Lai SL, Arepalli S, Hernandez D, Traynor BJ, Singleton A, Tienari PJ, Myllykangas L.

J Alzheimers Dis. 2011;26(2):377-85. doi: 10.3233/JAD-2011-102049.

19.

[Causative genes in Alzheimer's disease].

Urakami K, Wakutani Y, Wada-Isoe K, Yamagata K, Adachi Y, Nakashima K.

Nihon Ronen Igakkai Zasshi. 2001 Mar;38(2):117-20. Review. Japanese.

20.

The association of a cystatin C gene polymorphism with late-onset Alzheimer's disease and vascular dementia.

Lin C, Wang ST, Wu CW, Chuo LJ, Kuo YM.

Chin J Physiol. 2003 Sep 30;46(3):111-5.

PMID:
14672279

Supplemental Content

Support Center